Blocking Autophagy in Lung Macrophages Boosts Immune Priming Against Infections

A study published in Nature Immunology on 29 October 2026 reports that basal autophagy, the cell’s routine recycling process, restrains the lung’s first-line immune defenses. Wang and colleagues found that when autophagy is inactivated in alveolar macrophages, the immune cells lining the air sacs of the lung, these cells produce more of the inflammatory signaling molecule IL-1α. That change primes the innate immune system so effectively that mice clear respiratory infections faster and with less lung damage.

The researchers showed that autophagy normally suppresses the expression of the gene encoding IL-1α in alveolar macrophages. When autophagy genes were inactivated in these cells, IL-1α levels rose, which in turn enhanced IL-1 receptor–MyD88 signaling in neutrophils. This signaling cascade increased the recruitment of myeloid cells to the lung, strengthening the early response before adaptive immunity has time to act.

In mouse models, the consequences were measurable. Autophagy-deficient mice cleared the bacterium Staphylococcus aureus from the lung more efficiently and showed reduced lung damage and inflammation. The effect was not limited to one pathogen: the enhanced priming also improved resistance to influenza A virus, indicating that the mechanism operates broadly rather than against a single microbe.

The team took care to rule out alternative explanations. The protective effect persisted independently of the microbiome and of adaptive immunity, meaning the benefit arises from innate immune priming itself rather than from changes in resident bacteria or from antibody- and T-cell-mediated responses. Interferon signaling was also not required, according to the study’s figure-level findings on Atg14 deficiency.

Atg14, a component of the autophagy machinery, emerged as a central player. Genetic experiments indicated that ATG14 suppresses what the authors describe as tonic, or baseline, Il1a transcription in alveolar macrophages, thereby dampening resistance to pulmonary infections. The control of IL-1R agonist production occurred independently of inflammasomes, the multi-protein complexes often associated with IL-1 family cytokine release, pointing to a distinct regulatory route.

To test whether IL-1α alone could account for the protection, the researchers overexpressed the molecule in alveolar macrophages. This single intervention conferred broad-spectrum protection against both S. aureus and influenza A virus, mirroring the effect of genetic autophagy inactivation. The result suggests that IL-1α is sufficient to reproduce the priming phenotype, not merely correlated with it.

The findings reframe autophagy’s role in immunity. Rather than acting solely as an intracellular defense process, basal autophagy in alveolar macrophages appears to set the resting tone of the lung’s innate immune system. By keeping IL-1α production in check, it prevents excessive neutrophil-driven inflammation under normal conditions, but this restraint comes at a cost in readiness against incoming pathogens.

The authors suggest that manipulating this pathway could offer a strategy to fine-tune immune responses against important respiratory infections. Such applications remain speculative; the reported results come from mouse models of bacterial and viral pneumonia, and the study’s abstract notes that the mechanisms underlying innate immune priming were previously incompletely understood.

Because the work identifies a host-directed mechanism rather than an antimicrobial target, its implications extend across classes of respiratory pathogens. If the same autophagy–IL-1α axis operates in human alveolar macrophages, it could inform approaches to immune priming against both bacterial and viral lung infections, conditions for which resistance is initially determined by how well prepared the innate immune system is on first exposure to an invader.

Subject of Research: Autophagy regulation of IL-1α-mediated innate immune priming against respiratory infections in mice

Article Title: Autophagy in macrophages curtails IL-1α-mediated immune priming against lung infections

Article References: Cui, X., Zhang, X., Feng, S., Chen, J., Zhang, S., Sampedro, G. R., Gao, H., Irnov, I., Lu, Q., Baldridge, M. T., Boon, A. C. M., Cadwell, K., Torres, V. J., Bubeck Wardenburg, J., Chen, M., Liang, G., Virgin, H. W., Stallings, C. L., & Wang, Y.-T. (2026). Autophagy in macrophages curtails IL-1α-mediated immune priming against lung infections. Nature Immunology. https://doi.org/10.1038/s41590-026-02699-w

Image Credits: AI Generated

DOI: 10.1038/s41590-026-02699-w

Keywords: autophagy, alveolar macrophages, IL-1α, innate immunity, Staphylococcus aureus, influenza A virus, lung infection, neutrophils, immune priming, Atg14, MyD88 signaling, mouse models